ArchiveSee matrix →ES

Metabolic syndrome

Metabolic syndrome is a cluster of cardiometabolic abnormalities that frequently appear grouped together in the same person: central obesity (increased waist circumference), insulin resistance with dysglycemia, atherogenic dyslipidemia (triglyceri… Read more.

12 factors with evidence, ordered from most to least effective. Information, not medical advice.

See on the body →See in the matrix →

In depth

⏱ 3 min read

Metabolic syndrome is a cluster of cardiometabolic abnormalities that frequently appear together in the same person: central obesity (increased waist circumference), insulin resistance with dysglycemia, atherogenic dyslipidemia (high triglycerides, low HDL), and high blood pressure. The simultaneous presence of several of these abnormalities identifies people with significantly increased cardiovascular and type 2 diabetes risk, and constitutes one of the most important and, at the same time, most reversible therapeutic targets of modern preventive medicine.

Diagnostic criteria (modified ATP III)

3 or more of the following: - Waist circumference: ≥ 102 cm in men, ≥ 88 cm in women (Europe: ≥ 94 / ≥ 80). - Triglycerides: ≥ 150 mg/dL. - HDL: < 40 mg/dL in men, < 50 in women. - Blood pressure: ≥ 130/85 mmHg. - Fasting glucose: ≥ 100 mg/dL.

The unifying mechanism: insulin resistance

Insulin resistance is probably the unifying mechanism of metabolic syndrome. It begins with impaired muscle glucose uptake, progresses with compensatory hyperinsulinemia that has lipogenic effects in the liver (steatosis, hypertriglyceridemia), promotes accumulation of visceral fat with a proinflammatory profile, contributes to hypertension, and eventually leads to type 2 diabetes when pancreatic beta cells become exhausted.

What matters most: reversing the trigger

Significant weight loss: the most effective intervention. Losses of 5-10% reverse many components of metabolic syndrome.

Specific reduction of visceral fat: physical exercise (especially HIIT) is particularly effective.

Mediterranean diet: reduces incidence and improves components of metabolic syndrome.

Dramatic reduction of added sugars and concentrated fructose: sugary drinks are probably the single most relevant dietary factor.

Reduction of ultra-processed foods: they unfavorably change the hormonal and metabolic balance.

Regular physical exercise: moderate-to-vigorous aerobic exercise (150 min/week) + strength training (2-3 sessions).

Sufficient, regular sleep: sleep deprivation rapidly worsens insulin resistance.

Chronic stress management: elevated cortisol favors visceral accumulation.

Treat sleep apnea if present: a frequent cause of insulin resistance and hypertension.

Smoking cessation.

Supplements with modest support

Berberine (500 mg 2-3 times/day): the supplement with the best support for improving multiple components of metabolic syndrome simultaneously. Magnitudes comparable to low-dose metformin.

Inositol (myo + d-chiro): especially useful in women with PCOS and insulin resistance.

Magnesium: subclinical deficits are related to insulin resistance; correction is useful.

Omega-3 EPA/DHA: especially effective for triglycerides.

Vitamin D: deficits are associated with a worse metabolic profile.

Soluble fiber (psyllium, beta-glucans): improves glycemia and lipids.

Alpha-lipoic acid: modest support for insulin sensitivity.

Drugs: when

Metabolic syndrome per se has no specific pharmacological treatment; when its components are diagnosed (diabetes, dyslipidemia, hypertension), they are treated according to specific clinical guidelines. Modern drugs that have beneficial effects on multiple components simultaneously:

  • Metformin: in diabetes and prediabetes with PCOS or marked insulin resistance.
  • GLP-1 agonists (semaglutide, liraglutide, tirzepatide): enormous impact on weight loss, diabetes, and, in some contexts, lipids and blood pressure.
  • SGLT-2 inhibitors: in diabetes, with cardiovascular and renal benefits.

The reasonable conclusion

Metabolic syndrome is a highly reversible process in early stages with sustained lifestyle interventions: significant weight loss (especially visceral fat), a Mediterranean diet, elimination of sugary drinks and ultra-processed foods, regular physical exercise combining aerobic and strength training, sufficient sleep, and stress management. Supplements (especially berberine, magnesium if deficient, omega-3) are useful add-ons. Medical follow-up to treat specific components when the criteria are met is important; the ultimate goal is to prevent established diabetes and cardiovascular disease.

References

  1. Grundy, S.M. et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 17. doi:10.1161/CIRCULATIONAHA.105.169404
  2. Esposito, K. et al. (2014). Mediterranean diet and metabolic syndrome: an updated systematic review. Rev Endocr Metab Disord 14, 3. doi:10.1007/s11154-013-9253-9
  3. Yin, J.; Xing, H.; Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57, 5. doi:10.1016/j.metabol.2008.01.013
  4. Knowler, W.C. et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 6. doi:10.1056/NEJMoa012512
  5. Wilding, J.P.H. et al. (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 384, 11. doi:10.1056/NEJMoa2032183
Loading assistant…

Metabolic syndrome

⏱ 3 min read

Metabolic syndrome is a cluster of cardiometabolic abnormalities that frequently appear together in the same person: central obesity (increased waist circumference), insulin resistance with dysglycemia, atherogenic dyslipidemia (high triglycerides, low HDL), and high blood pressure. The simultaneous presence of several of these abnormalities identifies people with significantly increased cardiovascular and type 2 diabetes risk, and constitutes one of the most important and, at the same time, most reversible therapeutic targets of modern preventive medicine.

Diagnostic criteria (modified ATP III)

3 or more of the following: - Waist circumference: ≥ 102 cm in men, ≥ 88 cm in women (Europe: ≥ 94 / ≥ 80). - Triglycerides: ≥ 150 mg/dL. - HDL: < 40 mg/dL in men, < 50 in women. - Blood pressure: ≥ 130/85 mmHg. - Fasting glucose: ≥ 100 mg/dL.

The unifying mechanism: insulin resistance

Insulin resistance is probably the unifying mechanism of metabolic syndrome. It begins with impaired muscle glucose uptake, progresses with compensatory hyperinsulinemia that has lipogenic effects in the liver (steatosis, hypertriglyceridemia), promotes accumulation of visceral fat with a proinflammatory profile, contributes to hypertension, and eventually leads to type 2 diabetes when pancreatic beta cells become exhausted.

What matters most: reversing the trigger

Significant weight loss: the most effective intervention. Losses of 5-10% reverse many components of metabolic syndrome.

Specific reduction of visceral fat: physical exercise (especially HIIT) is particularly effective.

Mediterranean diet: reduces incidence and improves components of metabolic syndrome.

Dramatic reduction of added sugars and concentrated fructose: sugary drinks are probably the single most relevant dietary factor.

Reduction of ultra-processed foods: they unfavorably change the hormonal and metabolic balance.

Regular physical exercise: moderate-to-vigorous aerobic exercise (150 min/week) + strength training (2-3 sessions).

Sufficient, regular sleep: sleep deprivation rapidly worsens insulin resistance.

Chronic stress management: elevated cortisol favors visceral accumulation.

Treat sleep apnea if present: a frequent cause of insulin resistance and hypertension.

Smoking cessation.

Supplements with modest support

Berberine (500 mg 2-3 times/day): the supplement with the best support for improving multiple components of metabolic syndrome simultaneously. Magnitudes comparable to low-dose metformin.

Inositol (myo + d-chiro): especially useful in women with PCOS and insulin resistance.

Magnesium: subclinical deficits are related to insulin resistance; correction is useful.

Omega-3 EPA/DHA: especially effective for triglycerides.

Vitamin D: deficits are associated with a worse metabolic profile.

Soluble fiber (psyllium, beta-glucans): improves glycemia and lipids.

Alpha-lipoic acid: modest support for insulin sensitivity.

Drugs: when

Metabolic syndrome per se has no specific pharmacological treatment; when its components are diagnosed (diabetes, dyslipidemia, hypertension), they are treated according to specific clinical guidelines. Modern drugs that have beneficial effects on multiple components simultaneously:

The reasonable conclusion

Metabolic syndrome is a highly reversible process in early stages with sustained lifestyle interventions: significant weight loss (especially visceral fat), a Mediterranean diet, elimination of sugary drinks and ultra-processed foods, regular physical exercise combining aerobic and strength training, sufficient sleep, and stress management. Supplements (especially berberine, magnesium if deficient, omega-3) are useful add-ons. Medical follow-up to treat specific components when the criteria are met is important; the ultimate goal is to prevent established diabetes and cardiovascular disease.

References

  1. Grundy, S.M. et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 17. doi:10.1161/CIRCULATIONAHA.105.169404
  2. Esposito, K. et al. (2014). Mediterranean diet and metabolic syndrome: an updated systematic review. Rev Endocr Metab Disord 14, 3. doi:10.1007/s11154-013-9253-9
  3. Yin, J.; Xing, H.; Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57, 5. doi:10.1016/j.metabol.2008.01.013
  4. Knowler, W.C. et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 6. doi:10.1056/NEJMoa012512
  5. Wilding, J.P.H. et al. (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 384, 11. doi:10.1056/NEJMoa2032183